Long-term CD38 saturation by daratumumab interferes with diagnostic myeloma cell detection

• Anna Oberle,
• Anna Brandt,
• Malik Alawi,
• Claudia Langebrake,
• Snjezana Janjetovic,
• Christine Wolschke,
• Kerstin Schütze,
• Peter Bannas,
• Nicolaus Kröger,
• Friedrich Koch-Nolte,
• Carsten Bokemeyer,
• Mascha Binder

Affiliations

Anna Oberle

Department of Oncology and Hematology, Hubertus Wald Tumorzentrum, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Anna Brandt

Department of Oncology and Hematology, Hubertus Wald Tumorzentrum, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Malik Alawi

Bioinformatics Core, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Claudia Langebrake

Hospital Pharmacy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany;Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Snjezana Janjetovic

Department of Oncology and Hematology, Hubertus Wald Tumorzentrum, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Christine Wolschke

Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Kerstin Schütze

Institute for Immunology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Peter Bannas

Department of Radiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Nicolaus Kröger

Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Friedrich Koch-Nolte

Institute for Immunology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Carsten Bokemeyer

Department of Oncology and Hematology, Hubertus Wald Tumorzentrum, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Mascha Binder

Department of Oncology and Hematology, Hubertus Wald Tumorzentrum, University Medical Center Hamburg-Eppendorf, Hamburg, Germany